APA (7th ed.) Citation

P, M., J, S., N, S., R, B., F, F., A, G., . . . L, P. (2024). Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry. Hematological oncology, 42(1), e3240. https://doi.org/10.1002/hon.3240

Chicago Style (17th ed.) Citation

P, Musto, et al. "Survival in Multiple Myeloma and SARS-COV-2 Infection Through the COVID-19 Pandemic: Results from the EPICOVIDEHA Registry." Hematological Oncology 42, no. 1 (2024): e3240. https://doi.org/10.1002/hon.3240.

MLA (9th ed.) Citation

P, Musto, et al. "Survival in Multiple Myeloma and SARS-COV-2 Infection Through the COVID-19 Pandemic: Results from the EPICOVIDEHA Registry." Hematological Oncology, vol. 42, no. 1, 2024, p. e3240, https://doi.org/10.1002/hon.3240.